A chimeric IL-2/Ig molecule possesses the functional activity of both proteins - PubMed (original) (raw)

. 1991 Feb 1;146(3):915-9.

Affiliations

• PMID: 1988502

A chimeric IL-2/Ig molecule possesses the functional activity of both proteins

N F Landolfi. J Immunol. 1991.

Abstract

An expression vector (pIL-2/IgG1) was constructed with the coding sequence of human IL-2 inserted upstream of the four exons (CH1, hinge, CH2, and CH3) that encode the human IgG1 H chain constant region. Introduction of this vector into a nonsecreting murine myeloma cell line resulted in the production of a chimeric molecule (IL-2/IgG1) consisting of IL-2 attached to the three Ig constant region domains. This molecule was secreted by the transfectant as a homodimer. Functional characterization revealed that the IL-2/IgG1 chimeric molecule exhibited the binding and proliferation-mediating activities of IL-2. On a per molecule basis, IL-2/IgG1 was indistinguishable from human rIL-2 in the ability to induce the proliferation of an IL-2-dependent T cell line. This chimeric molecule also possesses Ig effector function, in that it can mediate the specific lysis of IL-2R-positive cells in the presence of complement. These results demonstrate that it is possible to maintain Ig effector function in molecules ("immunoligands") in which the binding specificity is conferred not by Ig variable regions, but rather, by a ligand of choice.

PubMed Disclaimer

Similar articles

• Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
  Chang Y, Prud'homme GJ. Chang Y, et al. J Gene Med. 1999 Nov-Dec;1(6):415-23. doi: 10.1002/(SICI)1521-2254(199911/12)1:6<415::AID-JGM66>3.0.CO;2-B. J Gene Med. 1999. PMID: 10753067
• Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
  Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK. Liao SK, et al. Hum Antibodies Hybridomas. 1990;1(2):66-76. Hum Antibodies Hybridomas. 1990. PMID: 2103354
• Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
  Wagner B, Robeson J, McCracken M, Wattrang E, Antczak DF. Wagner B, et al. Vet Immunol Immunopathol. 2005 May 1;105(1-2):1-14. doi: 10.1016/j.vetimm.2004.11.010. Vet Immunol Immunopathol. 2005. PMID: 15797470

Cited by

• Human fusion proteins between interleukin 2 and IgM heavy chain are cytotoxic for cells expressing the interleukin 2 receptor.
  Vié H, Gauthier T, Breathnach R, Bonneville M, Godard A, Dietrich J, Karam G, Gesnel MC, Peyrat MA, Jacques Y, Soulillou JP. Vié H, et al. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11337-41. doi: 10.1073/pnas.89.23.11337. Proc Natl Acad Sci U S A. 1992. PMID: 1454817 Free PMC article.
• A recombinant single chain antibody interleukin-2 fusion protein.
  Savage P, So A, Spooner RA, Epenetos AA. Savage P, et al. Br J Cancer. 1993 Feb;67(2):304-10. doi: 10.1038/bjc.1993.57. Br J Cancer. 1993. PMID: 8431359 Free PMC article.
• Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.
  Mealey RH, Leib SR, Littke MH, Wagner B, Horohov DW, McGuire TC. Mealey RH, et al. Vaccine. 2009 Apr 21;27(18):2453-68. doi: 10.1016/j.vaccine.2009.02.048. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19368787 Free PMC article.
• Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.
  Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL. Barouch DH, et al. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4192-7. doi: 10.1073/pnas.050417697. Proc Natl Acad Sci U S A. 2000. PMID: 10759543 Free PMC article.
• Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.
  Cedeno-Laurent F, Barthel SR, Opperman MJ, Lee DM, Clark RA, Dimitroff CJ. Cedeno-Laurent F, et al. J Immunol. 2010 Oct 15;185(8):4659-72. doi: 10.4049/jimmunol.1000715. Epub 2010 Sep 15. J Immunol. 2010. PMID: 20844192 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database